Profile for sandtibernhanongo
|
SignatureVernakalant is a potassium channel blocker launched for the acute, intravenous, treatment of atrial fibrillation. Vernakalant has activity for cardiac Na +, K + and atrial-selective Kv1.5 channels. Was launched for rapid conversion of recent onset atrial fibrillation to normal sinus rhythm in...
|
